VIR insider files Form 144 for 1,616 shares

VIR filed a Form 144 notice reporting proposed sales of common stock by an insider.

Rhea-AI Filing Summary

VIR filed a Form 144 notice reporting proposed sales of common stock by an insider. The filing lists 1,616 common shares associated with restricted stock vesting on 02/23/2026 and records 2,089 common shares listed under securities sold during the past three months on 02/23/2026 by Mark D. Eisner.

The transactions are tied to compensation-related vesting and a broker-dealer record for Fidelity Brokerage Services LLC appears on 02/24/2026.

Insights

Equity Capital Markets Analyst

Routine Form 144 shows insider-linked sales tied to restricted stock vesting.

The filing lists 1,616 common shares described as resulting from restricted stock vesting on 02/23/2026, indicating the shares became eligible for sale as part of compensation settlement. The filing also reports 2,089 common shares sold by Mark D. Eisner on 02/23/2026.

These items are administrative disclosures of an insider transaction; cash-flow treatment and net proceeds details are not included in the provided excerpt. Subsequent filings or broker confirmations would show execution details if available.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VIR's Form 144 say about shares to be sold?

The Form 144 lists 1,616 common shares tied to restricted stock vesting on 02/23/2026. It records that these shares became eligible for sale as part of compensation-related vesting; the excerpt does not state execution timing or proceeds.

How many shares did Mark D. Eisner report selling for VIR?

The filing shows 2,089 common shares listed under securities sold during the past three months on 02/23/2026. This entry appears in the insider sales section; the excerpt does not include sale price or net proceeds information.

Is the VIR Form 144 tied to a broker-dealer?

Yes—Fidelity Brokerage Services LLC is listed with a record date of 02/24/2026. The broker-dealer entry appears alongside the securities information, consistent with standard brokerage handling of insider transactions.

Are the shares in the Form 144 from compensation or open-market sales?

The excerpt indicates 1,616 shares resulted from restricted stock vesting (compensation) on 02/23/2026. The 2,089-share entry for Mark D. Eisner is in the sold-in-past-three-months section, but the excerpt does not specify method (open-market or other).

Does the Form 144 disclose proceeds or sale prices for VIR transactions?

The provided excerpt does not include sale prices or aggregate proceeds. It lists share counts and dates tied to vesting and prior sales, but execution price and cash-flow details are not present in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 05:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001834161
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vir Biotechnology, Inc.
SEC File Number	001-39083
Address of Issuer	1800 OWENS STREET SUITE 900 SAN FRANCISCO CALIFORNIA 94158
Phone	415-906-4324
Name of Person for Whose Account the Securities are To Be Sold	Eisner Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1616	15404.68	139517278	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Restricted Stock Vesting	Issuer			1616	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark D. Eisner 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/23/2026	2089	15568.90

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Mark Eisner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)